Replies to post #60306 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

the limited details pertaining to direct appear to be getting better with time.

You do kind of get that sense, they're working towards something.

If there were problems, they likely would't even include those comments in the press release...well over 300 patients and on-going dialogue.

The Company's Phase III trial of DCVax-L for GBM brain cancer is ongoing. As previously announced, well over 300 patients have been enrolled in the trial and the patients are continuing to be treated in accordance with the trial protocol. The trial remains subject to a partial clinical hold on screening of additional patient candidates. The Company is in ongoing dialog with regulators, and providing further information